Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Perspective Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CATX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1041105+2
Shares247.7M106.9K38.7M−208.9M (−84.4%)
Value$294.6M$127.2K$384.9M+$90.4M (+30.7%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CATX in Q2 2024
InstitutionSharesValue% of portfolio
Avidity Partners Management LP3,037,668$30.3M1.29%
Paradigm Biocapital Advisors LP919,692$9.17M0.35%
Walleye Capital LLC512,823$5.11M0.05%
Rock Springs Capital Management LP401,196$4.00M0.12%
Ally Bridge Group (NY) LLC396,242$3.95M2.35%
Adage Capital Partners GP, L.L.C.381,640$3.80M0.01%
StemPoint Capital LP343,810$3.43M1.01%
Eagle Asset Management Inc241,679$2.71M0.01%
Nuveen Asset Management, LLC260,927$2.60M0.00%
WealthPLAN Partners, LLC169,963$1.69M0.18%
Atika Capital Management LLC142,499$1.42M0.16%
HighVista Strategies LLC113,550$1.13M0.41%
Sandler Capital Management106,697$1.06M0.21%
Superstring Capital Management LP87,638$873.8K1.10%
UBS Oconnor LLC85,013$847.6K0.02%
Winton Group Ltd84,363$841.1K0.06%
Swiss National Bank69,260$690.5K0.00%
Y-Intercept (Hong Kong) Ltd63,581$633.9K0.03%
Rhumbline Advisers63,170$629.8K0.00%
UBS Asset Management Americas Inc55,467$553.0K0.00%
ClariVest Asset Management LLC54,199$540.4K0.06%
Alpine Global Management, LLC44,714$445.8K0.08%
Legal & General Group Plc36,375$362.7K0.00%
California State Teachers Retirement System35,364$352.6K0.00%
Corebridge Financial, Inc.25,333$252.8K0.00%
State of Wisconsin Investment Board24,390$243.2K0.00%
Alliancebernstein L.P.24,320$242.5K0.00%
Invesco Ltd.23,523$234.5K0.00%
New York State Common Retirement Fund19,000$189.4K0.00%
Manufacturers Life Insurance Company, The18,842$187.9K0.00%
Voloridge Investment Management, LLC15,963$159.2K0.00%
Voya Investment Management LLC15,869$158.2K0.00%
MetLife Investment Management12,028$119.9K0.00%
Point72 (DIFC) Ltd11,842$118.1K0.01%
Victory Capital Management Inc11,770$117.3K0.00%
Sectoral Asset Management Inc11,000$109.7K0.04%
STRS Ohio8,700$86.7K0.00%
Virtus ETF Advisers LLC7,803$77.8K0.04%
Ameritas Investment Partners, Inc.4,613$46.0K0.00%
US Bancorp2,710$27.0K0.00%
Amalgamated Bank1,629$16.0K0.00%
Carolinas Wealth Consulting LLC1,097$10.9K0.00%
Deutsche Bank AG948$9.45K0.00%
State of Wyoming572$5.71K0.00%
Lazard Asset Management LLC523$5.00K0.00%
Farther Finance Advisors, LLC348$3.90K0.00%
Headlands Technologies LLC152$1.51K0.00%
Planning Capital Management Corp110$1.10K0.00%
International Assets Investment Management, LLC90$8970.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC51$5080.00%
Price T Rowe Associates Inc15,019$00.00%

Sold out (49)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CATX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Hills Bank & Trust Co10,358,305$12.3M
Laurion Capital Management LP8,918,918$10.6M
Goldman Sachs Group Inc1,996,511$2.38M
Hudson Bay Capital Management LP850,000$1.01M
Tri Locum Partners LP780,303$928.6K
Mayo Clinic724,641$862.3K
Atom Investors LP551,279$656.0K
Susquehanna International Group, LLP535,293$637.0K
Cubist Systematic Strategies, LLC527,470$627.7K
Taylor & Morgan Wealth Management, LLC250,000$297.5K
Baker Bros. Advisors LP149,787$178.2K
HRT Financial LP122,167$145.0K
Virtu Financial LLC115,762$138.0K
LMR Partners LLP115,488$137.4K
Balyasny Asset Management LLC111,723$132.9K
Polymer Capital Management (HK) LTD103,773$123.5K
Ameriprise Financial Inc93,201$110.9K
Vontobel Holding Ltd.80,000$95.2K
CTC Alternative Strategies, Ltd.69,900$83.2K
Commonwealth Equity Services, LLC48,284$57.0K
Mariner, LLC47,778$56.9K
Marathon Trading Investment Management LLC47,000$55.9K
Omers Administration Corp45,200$53.8K
Jefferies Financial Group Inc.43,500$51.8K
Thrivent Financial for Lutherans40,000$48.0K
Cerity Partners LLC40,000$47.6K
Brevan Howard Capital Management LP38,994$46.4K
Simplicity Wealth,LLC33,570$39.9K
Bleakley Financial Group, LLC33,570$39.9K
Squarepoint Ops LLC28,990$34.5K
TradeLink Capital LLC27,000$32.0K
Two Sigma Advisers, LP23,100$27.5K
HighPoint Advisor Group LLC15,700$27.0K
ZWJ Investment Counsel Inc22,000$26.2K
Wealth Advisors of Iowa, LLC20,000$23.8K
Raymond James Financial Services Advisors, Inc.18,450$22.0K
Congress Wealth Management LLC15,000$17.9K
Prudential Financial Inc14,400$17.1K
Twinbeech Capital LP14,377$17.1K
Two Sigma Securities, LLC14,152$16.8K
Cetera Investment Advisers12,500$14.9K
Great Valley Advisor Group, Inc.12,000$14.3K
Tower Research Capital LLC (TRC)10,881$12.9K
Auxier Asset Management10,218$12.2K
Capital Advisors Inc10,000$11.9K
Old Point Trust & Financial Services N A2,500$2.98K
Scarborough Advisors, LLC109$130
Macquarie Group Ltd13,988$17
Mercer Global Advisors Inc4–

Not filed for Q2 2024 yet (1)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CATX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
RIA Advisory Group LLC106,853$127.2K